C4 THERAPEUTICS INC shareholders Q3 2023

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 84 filers reported holding C4 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.83 and the average weighting 0.1%.

C4 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CWM, LLC 110$00.00%
BANK OF AMERICA CORP /DE/ 45,341$84,3340.00%
Russell Investments Group, Ltd. 95,822$178,2280.00%
WELLS FARGO & COMPANY/MN 334$6210.00%
NORTHERN TRUST CORP 90,992$169,2450.00%
AMERICAN CENTURY COMPANIES INC 31,796$59,1410.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 455,844$848,0930.00%
STATE STREET CORP 155,373$288,9940.00%
Corient Private Wealth LLC 12,695$23,6130.00%
RAYMOND JAMES & ASSOCIATES 91,380$169,9580.00%
SG Americas Securities, LLC 11,921$220.00%
EverSource Wealth Advisors, LLC 448$8330.00%
FEDERATED HERMES, INC. 3,141$5,8420.00%
NISA INVESTMENT ADVISORS, LLC 490$9110.00%
AMERIPRISE FINANCIAL INC 69,486$129,2440.00%
CITIGROUP INC 57,894$107,6830.00%
STATE OF WISCONSIN INVESTMENT BOARD 30,200$56,1720.00%
HSBC HOLDINGS PLC 32,653$62,0410.00%
VANGUARD GROUP INC 1,924,856$3,580,2320.00%
External links

This page lists C4 THERAPEUTICS INC's shareholders in Q3 2023. To view C4 THERAPEUTICS INC's shareholder history, click here.